Sylvain Thierry

863 total citations
21 papers, 501 citations indexed

About

Sylvain Thierry is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Sylvain Thierry has authored 21 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Virology and 8 papers in Infectious Diseases. Recurrent topics in Sylvain Thierry's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (8 papers) and DNA Repair Mechanisms (7 papers). Sylvain Thierry is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (8 papers) and DNA Repair Mechanisms (7 papers). Sylvain Thierry collaborates with scholars based in France, Germany and United States. Sylvain Thierry's co-authors include Olivier Delelis, Frédéric Subra, Eric Deprez, Vincent Maréchal, Marie Dutreix, Joël Gozlan, Brigitte Janvier, Michel Raymondjean, Michèlle Rosenzwajg and Gérard Redeuilh and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Sylvain Thierry

21 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvain Thierry France 12 264 250 234 83 58 21 501
Ryan J. Conrad United States 5 382 1.4× 195 0.8× 112 0.5× 89 1.1× 43 0.7× 7 571
Kyle J. Seamon United States 13 271 1.0× 146 0.6× 63 0.3× 137 1.7× 93 1.6× 17 535
Huanan Liao Japan 9 162 0.6× 178 0.7× 169 0.7× 16 0.2× 105 1.8× 14 439
Yongjian Lu United States 11 310 1.2× 287 1.1× 174 0.7× 92 1.1× 157 2.7× 16 594
Evelien Rondelez Belgium 11 234 0.9× 294 1.2× 267 1.1× 27 0.3× 46 0.8× 19 479
John Bui United States 10 184 0.7× 251 1.0× 174 0.7× 173 2.1× 75 1.3× 12 567
Jacqueline Bixby United States 6 308 1.2× 135 0.5× 79 0.3× 225 2.7× 119 2.1× 9 512
Tiffany Barnes United States 12 339 1.3× 298 1.2× 296 1.3× 80 1.0× 83 1.4× 20 667
Annika Sanfridson United States 10 251 1.0× 318 1.3× 153 0.7× 260 3.1× 120 2.1× 17 710
Keiko Kajiwara Japan 9 116 0.4× 177 0.7× 153 0.7× 55 0.7× 41 0.7× 12 412

Countries citing papers authored by Sylvain Thierry

Since Specialization
Citations

This map shows the geographic impact of Sylvain Thierry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Thierry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Thierry more than expected).

Fields of papers citing papers by Sylvain Thierry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Thierry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Thierry. The network helps show where Sylvain Thierry may publish in the future.

Co-authorship network of co-authors of Sylvain Thierry

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Thierry. A scholar is included among the top collaborators of Sylvain Thierry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Thierry. Sylvain Thierry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naour, Julie Le, Sylvain Thierry, Sarah Adriana Scuderi, et al.. (2023). A Chemically Defined TLR3 Agonist with Anticancer Activity. OncoImmunology. 12(1). 2227510–2227510. 7 indexed citations
2.
3.
Herath, Nirmitha I., Nathalie Berthault, Sylvain Thierry, et al.. (2019). Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors. Frontiers in Oncology. 9. 1097–1097. 14 indexed citations
4.
Alekseev, Sergey, et al.. (2019). AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance. Neoplasia. 21(9). 863–871. 11 indexed citations
5.
Richetta, Clémence, Sylvain Thierry, Paul Lesbats, et al.. (2019). Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase. Journal of Biological Chemistry. 294(20). 8286–8295. 9 indexed citations
6.
Thierry, Sylvain, et al.. (2017). Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA. Cancer Research. 77(16). 4207–4216. 24 indexed citations
7.
Thierry, Sylvain, et al.. (2017). The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood. Molecular Cancer Therapeutics. 16(12). 2817–2827. 11 indexed citations
8.
Thierry, Sylvain, Flavien Devun, Muthana Al Abo, et al.. (2016). Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors. Clinical Cancer Research. 23(4). 1001–1011. 29 indexed citations
9.
Thierry, Sylvain, Frédéric Subra, Eric Deprez, et al.. (2016). Opposite transcriptional regulation of integrated vs unintegrated HIV genomes by the NF-κB pathway. Scientific Reports. 6(1). 25678–25678. 7 indexed citations
10.
11.
Thierry, Sylvain, Ludivine Sinzelle, Christina Calmels, et al.. (2015). Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration. Chemistry & Biology. 22(6). 712–723. 9 indexed citations
12.
Thierry, Sylvain, Frédéric Subra, Hervé Leh, et al.. (2015). Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration. Retrovirology. 12(1). 24–24. 36 indexed citations
13.
Dufour, Noëlle, Sylvain Thierry, Olivier Delelis, et al.. (2014). Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant. Molecular Therapy — Nucleic Acids. 3. e213–e213. 7 indexed citations
14.
Corona, Angela, Francesco Saverio Di Leva, Sylvain Thierry, et al.. (2014). Identification of Highly Conserved Residues Involved in Inhibition of HIV-1 RNase H Function by Diketo Acid Derivatives. Antimicrobial Agents and Chemotherapy. 58(10). 6101–6110. 61 indexed citations
15.
Thierry, Sylvain, et al.. (2013). Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle. Retrovirology. 10(1). 87–87. 56 indexed citations
16.
Manic, Gwenola, Frédéric Laurent, Ilio Vitale, et al.. (2013). Impact of the Ku Complex on HIV-1 Expression and Latency. PLoS ONE. 8(7). e69691–e69691. 22 indexed citations
17.
Delelis, Olivier, Alessia Zamborlini, Sylvain Thierry, & Ali Saı̈b. (2009). Chromosomal tethering and proviral integration. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1799(3-4). 207–216. 6 indexed citations
18.
Delelis, Olivier, Sylvain Thierry, Frédéric Subra, et al.. (2009). Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In Vivo. Antimicrobial Agents and Chemotherapy. 54(1). 491–501. 63 indexed citations
19.
Thierry, Sylvain, et al.. (2007). High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells. AIDS. 21(3). 283–292. 27 indexed citations
20.
Thierry, Sylvain, et al.. (2006). Activation of sPLA2‐IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL‐1β. The FASEB Journal. 20(10). 1727–1729. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan J. Conrad Breakdown of academic impact, for papers by Kyle J. Seamon Breakdown of academic impact, for papers by Huanan Liao Breakdown of academic impact, for papers by Yongjian Lu Breakdown of academic impact, for papers by Evelien Rondelez Breakdown of academic impact, for papers by John Bui Breakdown of academic impact, for papers by Jacqueline Bixby Breakdown of academic impact, for papers by Tiffany Barnes Breakdown of academic impact, for papers by Annika Sanfridson Breakdown of academic impact, for papers by Keiko Kajiwara
Rankless by CCL
2026